Engineering digital biomarkers of interstitial glucose from noninvasive smartwatches

npj Digital Medicine

Brinnae Bent, Peter J. Cho, Maria Henriquez, April Wittmann, Connie Thacker, Mark Feinglos, Matthew J. Crowley & Jessilyn P. Dunn

Infographic showing objectives of the research

Summary

Prediabetes affects one in three people and has a 10% annual conversion rate to type 2 diabetes without lifestyle or medical interventions. Management of glycemic health is essential to prevent progression to type 2 diabetes. However, there is currently no commercially-available and noninvasive method for monitoring glycemic health to aid in self-management of prediabetes. There is a critical need for innovative, practical strategies to improve monitoring and management of glycemic health. In this study, using a dataset of 25,000 simultaneous interstitial glucose and noninvasive wearable smartwatch measurements, we demonstrated the feasibility of using noninvasive and widely accessible methods, including smartwatches and food logs recorded over 10 days, to continuously detect personalized glucose deviations and to predict the exact interstitial glucose value in real time with up to 84% and 87% accuracy, respectively. We also establish methods for designing variables using data-driven and domain-driven methods from noninvasive wearables toward interstitial glucose prediction.

Citation

Bent, Brinnae, et al. “Engineering digital biomarkers of interstitial glucose from noninvasive smartwatches.” NPJ Digital Medicine 4.1 (2021): 89.

BibTex

@article{bent2021engineering, title={Engineering digital biomarkers of interstitial glucose from noninvasive smartwatches}, author={Bent, Brinnae and Cho, Peter J and Henriquez, Maria and Wittmann, April and Thacker, Connie and Feinglos, Mark and Crowley, Matthew J and Dunn, Jessilyn P}, journal={NPJ Digital Medicine}, volume={4}, number={1}, pages={89}, year={2021}, publisher={Nature Publishing Group UK London} }

Collaborators: